Search - tctmd.com

Displaying 1 - 20 of 260

Sort: Relevancy | Date

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Who to Treat With TTVI?

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

Presenter: Alexandra Lackey

October 30, 2024

Presentation TCT 2024

TCT 983: Innovative Approach to Right Sided Endocarditis

Presenter: Bahjat Aladili

October 30, 2024

Presentation TCT 2024

TCT 982: The Safety of Catheter Aspiration of Tricuspid Valve Endocarditis Versus Open Surgery

Presenter: Rohan A Shah

October 30, 2024

Presentation TCT 2024

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Alexander Lauten

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Mark Lebehn

October 30, 2024

Presentation TCT 2024

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Case Resolution

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

Topic 4: TTVR - Balancing Bleeding Risks and Thrombosis

Presenter: Geraldine Ong

October 29, 2024

Advertisement

Patient Considerations

Imaging Considerations

Who to Treat With TTVI?

How to Manage After TTVI?

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

TCT 983: Innovative Approach to Right Sided Endocarditis

TCT 982: The Safety of Catheter Aspiration of Tricuspid Valve Endocarditis Versus Open Surgery

How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Case Presentation

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Case Resolution

Case Presentation

Topic 4: TTVR - Balancing Bleeding Risks and Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content